Literature DB >> 12646537

Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

J A Critchley1, S Capewell.   

Abstract

STUDY
OBJECTIVE: The UK government called for a 40% reduction in cardiovascular disease mortality in those aged under 75 by 2010. This paper examines the potential for cardiovascular risk factor changes to reduce coronary heart disease deaths in Scotland, and then extrapolates the findings to the UK population.
DESIGN: Secondary analysis of published data using a previously validated mortality model. The model combines uptake and effectiveness of treatments with risk factor trends by sex and age group. It was used to estimate the expected reductions in coronary heart disease mortality: (a) if recent risk factor trends simply continued; (b) if additional risk factor reductions were achieved in line with Scandinavia and the United States. An "analysis of extremes" sensitivity analysis was then carried out.
SETTING: Scotland and UK. PARTICIPANTS: Projected Scottish population aged 45+ in 2010 (2.4 million) and UK population of 26.8 million. MAIN
RESULTS: Continuation of current trends would result in 2169 fewer coronary deaths in 2010 (minimum estimate 1191 from sensitivity analyses to maximum 3870). About 4749 fewer deaths (minimum 3085, maximum 7155) could be achieved by: (a) a reduction in smoking prevalence from 30% to 18% (about 1668 fewer deaths); (b) a mean population cholesterol reduction from 6.2 to 5.2 mmol/l (about 2167 fewer deaths); (c) a 3.7 mm Hg fall in diastolic blood pressure (about 914 fewer deaths). Extrapolation from the Scottish population to the UK suggests 24 000 fewer deaths in 2010 if current trends continue, or 53 000 fewer deaths with the additional reductions.
CONCLUSIONS: With additional interventions it would be possible to almost halve current UK coronary heart disease mortality. Even without gains from medical treatments, the UK government target of 28 000 fewer deaths in 2010 does not seem challenging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646537      PMCID: PMC1732418          DOI: 10.1136/jech.57.4.243

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  25 in total

1.  The health benefits of prevention: a simulation approach.

Authors:  L Gunning-Schepers
Journal:  Health Policy       Date:  1989-07       Impact factor: 2.980

2.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment.

Authors:  M G Hunink; L Goldman; A N Tosteson; M A Mittleman; P A Goldman; L W Williams; J Tsevat; M C Weinstein
Journal:  JAMA       Date:  1997-02-19       Impact factor: 56.272

3.  Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example.

Authors:  A Dobson; B Filipiak; K Kuulasmaa; R Beaglehole; A Stewart; M Hobbs; R Parsons; U Keil; E Greiser; H Korhonen; J Tuomilehto
Journal:  Am J Epidemiol       Date:  1996-05-15       Impact factor: 4.897

4.  Decline in ischaemic heart disease in Iceland and change in risk factor levels.

Authors:  N Sigfusson; H Sigvaldason; L Steingrimsdottir; I I Gudmundsdottir; I Stefansdottir; T Thorsteinsson; G Sigurdsson
Journal:  BMJ       Date:  1991-06-08

5.  Medical management and the decline in mortality from coronary heart disease.

Authors:  R Beaglehole
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

6.  Opportunities for control of coronary heart disease in Australia.

Authors:  P McElduff; A J Dobson; K Jamrozik; M S Hobbs
Journal:  Aust N Z J Public Health       Date:  2001       Impact factor: 2.939

7.  Expected gains in life expectancy from various coronary heart disease risk factor modifications.

Authors:  J Tsevat; M C Weinstein; L W Williams; A N Tosteson; L Goldman
Journal:  Circulation       Date:  1991-04       Impact factor: 29.690

Review 8.  Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.

Authors:  S Yusuf; J Lessem; P Jha; E Lonn
Journal:  J Hypertens Suppl       Date:  1993-06

9.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

10.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.

Authors:  A G Shaper; S J Pocock; M Walker; N M Cohen; C J Wale; A G Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18
View more
  16 in total

1.  Urban-rural inequalities in ischemic heart disease in Scotland, 1981-1999.

Authors:  Kate A Levin; Alastair H Leyland
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

2.  Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America.

Authors:  Simon Capewell; Earl S Ford; Janet B Croft; Julia A Critchley; Kurt J Greenlund; Darwin R Labarthe
Journal:  Bull World Health Organ       Date:  2009-12-08       Impact factor: 9.408

3.  Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.

Authors:  I Gemmell; R F Heller; K Payne; R Edwards; M Roland; P Durrington
Journal:  Qual Saf Health Care       Date:  2006-10

4.  Changes in lifestyle after hypertension diagnosis in Canada.

Authors:  C Ineke Neutel; Norm R C Campbell
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

5.  Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006.

Authors:  Thor Aspelund; Vilmundur Gudnason; Bergrun Tinna Magnusdottir; Karl Andersen; Gunnar Sigurdsson; Bolli Thorsson; Laufey Steingrimsdottir; Julia Critchley; Kathleen Bennett; Martin O'Flaherty; Simon Capewell
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

6.  Assessing patterns of use of cardio-protective polypill component medicines in Australian women.

Authors:  Jennifer A Stewart Williams; Christopher J Wallick; Julie E Byles; Christopher M Doran
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

7.  Deprivation and trends in blood pressure, cholesterol, body mass index and smoking among participants of a UK primary care-based cardiovascular risk factor screening programme: both narrowing and widening in cardiovascular risk factor inequalities.

Authors:  G Lyratzopoulos; R F Heller; P McElduff; M Hanily; P Lewis
Journal:  Heart       Date:  2006-02-08       Impact factor: 5.994

8.  Quantifying options for reducing coronary heart disease mortality by 2020.

Authors:  Mark D Huffman; Donald M Lloyd-Jones; Hongyan Ning; Darwin R Labarthe; Maria Guzman Castillo; Martin O'Flaherty; Earl S Ford; Simon Capewell
Journal:  Circulation       Date:  2013-05-09       Impact factor: 29.690

9.  The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.

Authors:  Jun Cheng; Dong Zhao; Zhechun Zeng; Julia Alison Critchley; Jing Liu; Wei Wang; Jiayi Sun; Simon Capewell
Journal:  BMC Public Health       Date:  2009-01-22       Impact factor: 3.295

10.  Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006.

Authors:  Samer Rastam; Radwan Al Ali; Wasim Maziak; Fawaz Mzayek; Fouad M Fouad; Martin O'Flaherty; Simon Capewell
Journal:  BMC Public Health       Date:  2012-09-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.